Cargando…
P1106: PRELIMINARY RESULTS OF A PHASE 1 STUDY OF NOVEL BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) IN CHINESE PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMAS (NHLS)
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430675/ http://dx.doi.org/10.1097/01.HS9.0000847292.19961.d6 |
| _version_ | 1784779839855656960 |
|---|---|
| author | Sun, M. Qi, J. Song, Y. Zhou, K. Liu, H. Shen, A. Geng, L. Zhou, F. Huang, J. Chen, Z. Zhang, H. Lu, M. Ahmad, M. Men, L. Yang, D. Zhai, Y. Wang, J. |
| author_facet | Sun, M. Qi, J. Song, Y. Zhou, K. Liu, H. Shen, A. Geng, L. Zhou, F. Huang, J. Chen, Z. Zhang, H. Lu, M. Ahmad, M. Men, L. Yang, D. Zhai, Y. Wang, J. |
| author_sort | Sun, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430675 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94306752022-08-31 P1106: PRELIMINARY RESULTS OF A PHASE 1 STUDY OF NOVEL BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) IN CHINESE PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMAS (NHLS) Sun, M. Qi, J. Song, Y. Zhou, K. Liu, H. Shen, A. Geng, L. Zhou, F. Huang, J. Chen, Z. Zhang, H. Lu, M. Ahmad, M. Men, L. Yang, D. Zhai, Y. Wang, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430675/ http://dx.doi.org/10.1097/01.HS9.0000847292.19961.d6 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Sun, M. Qi, J. Song, Y. Zhou, K. Liu, H. Shen, A. Geng, L. Zhou, F. Huang, J. Chen, Z. Zhang, H. Lu, M. Ahmad, M. Men, L. Yang, D. Zhai, Y. Wang, J. P1106: PRELIMINARY RESULTS OF A PHASE 1 STUDY OF NOVEL BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) IN CHINESE PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMAS (NHLS) |
| title | P1106: PRELIMINARY RESULTS OF A PHASE 1 STUDY OF NOVEL BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) IN CHINESE PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMAS (NHLS) |
| title_full | P1106: PRELIMINARY RESULTS OF A PHASE 1 STUDY OF NOVEL BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) IN CHINESE PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMAS (NHLS) |
| title_fullStr | P1106: PRELIMINARY RESULTS OF A PHASE 1 STUDY OF NOVEL BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) IN CHINESE PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMAS (NHLS) |
| title_full_unstemmed | P1106: PRELIMINARY RESULTS OF A PHASE 1 STUDY OF NOVEL BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) IN CHINESE PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMAS (NHLS) |
| title_short | P1106: PRELIMINARY RESULTS OF A PHASE 1 STUDY OF NOVEL BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) IN CHINESE PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMAS (NHLS) |
| title_sort | p1106: preliminary results of a phase 1 study of novel bcl-2 inhibitor lisaftoclax (apg-2575) in chinese patients (pts) with relapsed or refractory (r/r) non-hodgkin lymphomas (nhls) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430675/ http://dx.doi.org/10.1097/01.HS9.0000847292.19961.d6 |
| work_keys_str_mv | AT sunm p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT qij p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT songy p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT zhouk p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT liuh p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT shena p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT gengl p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT zhouf p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT huangj p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT chenz p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT zhangh p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT lum p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT ahmadm p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT menl p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT yangd p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT zhaiy p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls AT wangj p1106preliminaryresultsofaphase1studyofnovelbcl2inhibitorlisaftoclaxapg2575inchinesepatientsptswithrelapsedorrefractoryrrnonhodgkinlymphomasnhls |